Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Molecular Characterization of Advanced Stage Melanoma by Blood Sampling
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Imaging FDG Flare in Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab-induced Lung Toxicity: Observational Study
- Status
- COMPLETED
- Phase
- N/A
Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
- Status
- TERMINATED
- Phase
- PHASE2
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2